| Net Cash Provided by (Used in) Operating Activities |
$1,906,890 |
USD |
19% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$45,615 |
USD |
71% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$550,987 |
USD |
35% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
184,735 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0.5 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,310,288 |
USD |
120% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$3,923,822 |
USD |
-25% |
Q4 2024 |
FY 2024 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$11,844 |
USD |
-9.2% |
Q1 2025 |
Q1 2025 |
| Depreciation |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$349,746 |
USD |
-52% |
Q2 2024 |
Q2 2024 |
| Deferred Income Tax Expense (Benefit) |
$488,094 |
USD |
86% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$172,544 |
USD |
|
Q4 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
$156,991 |
USD |
-0.68% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,669,637 |
USD |
24% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$16,149 |
USD |
-3.8% |
Q1 2025 |
Q1 2025 |